Opdualag

(nivolumab / relatlimab)

Opdualag 240 MG / 80 MG in 20 ML Injection

NO BLACK BOX WARNING

Dosage & administration

* Adult patients and pediatric patients 12 years of age or older who weigh at least 40 kg: 480 mg nivolumab and 160 mg relatlimab intravenously every 4 weeks. (2)
* Administer OPDUALAG as an intravenous infusion over 30 minutes. (2)
* See full Prescribing Information for dosage modifications for adverse reactions (2.2) and preparation and administration instructions for the injection (2.3).

biomarker testing

Opdualag clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Opdualag prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Opdualag prior authorization resources

Most recent Opdualag prior authorization forms

View By Payer

Verified: Sep 28, 2023Cigna - Opdualag Prior Authorization Form

Verified: Sep 21, 2023Aetna - Opdualag Prior Authorization Form

PDFComplete Letter of Medical Necessity

PDFCoverage Authorization Appeals

PDFCommercial Claim Denial Appeal/Redetermination Letter

PDFMedically Unlikely Edit (MUE) Appeal Letter

Learn More

Benefits investigation

PDFOpdualag Enrollment Form

PDFOpdualag Enrollment Form - Spanish

Learn More

Reimbursement help (FRM)

OTHERReceive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Opdualag financial assistance options

Co-pay savings program

commercial only

PDFOpdualag Enrollment Form

PDFOpdualag Enrollment Form - Spanish

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFOpdualag Enrollment Form

PDFOpdualag Enrollment Form - Spanish

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Opdualag patient education

Getting started on Opdualag

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link